• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 12 of 100
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
HealthNew COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By Lindsey LeakeAugust 29, 2024
Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma
CommentaryBig Tech wants to keep stealing patents—so it’s going to war with Big Pharma
By Andrei Iancu and David J. KapposAugust 28, 2024
Novo Nordisk’s weight-loss drugs and Bavarian Nordic’s mpox vaccine help fatten up the Danish economy
FinanceNovo Nordisk’s weight-loss drugs and Bavarian Nordic’s mpox vaccine help fatten up the Danish economy
By Sanne Wass and BloombergAugust 20, 2024
The three founders of Photon Health sitting on a brown sofa and posing for a photo.
TechThis startup believes shopping around for prescription drugs should be as easy as shopping on Amazon. The future of a $700 billion industry is at stake
By Jason Del ReyAugust 15, 2024
MeAgainMeds.com, a free tool developed by researchers at the George Mason University College of Public Health in Fairfax, Va., uses AI to pair people with depression with the best available antidepressant medication for them.
MindAntidepressant not working? AI may do a better job than your doctor in matching you with the best medicine
By Lindsey LeakeAugust 14, 2024
Exclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
HealthExclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
By Alexa MikhailAugust 14, 2024
Here’s the real reason Ozempic-like weight-loss drugs are so popular
CommentaryHere’s the real reason Ozempic-like weight-loss drugs are so popular
By Bill NovelliAugust 12, 2024
FDA sign
HealthFDA rejects psychedelic drug MDMA as a treatment for PTSD
By Matthew Perrone and The Associated PressAugust 10, 2024
Lars Fruergaard Jorgensen
HealthWegovy is finally more widely available—and it’s bad news for Novo Nordisk’s profits
By BloombergAugust 7, 2024
An Ozempic (semaglutide) injection pen is seen on a kitchen table.
HealthHow Denmark got homegrown giant Novo Nordisk to lower Ozempic prices
By Arthur Allen and KFF Health NewsAugust 7, 2024
Teens are getting colorectal cancer at unprecedented rates—but a little-known IRA provision is blocking new lifesaving treatments
CommentaryTeens are getting colorectal cancer at unprecedented rates—but a little-known IRA provision is blocking new lifesaving treatments
By Michael SapienzaAugust 2, 2024
How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
MagazineHow Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
By Erika FryAugust 2, 2024
Only an AI breakthrough can help humans live longer, argues drug developer: ‘We need a ChatGPT moment in longevity’
ConferencesOnly an AI breakthrough can help humans live longer, argues drug developer: ‘We need a ChatGPT moment in longevity’
By Christiaan HetznerJuly 31, 2024
Angela Fitch. cofounder and chief medical officer of knownwell.
CommentaryI’m an obesity medicine doctor and I’ve been on weight-loss drugs like Ozempic for a decade. Here’s why I think they aren’t a fad
By Angela FitchJuly 30, 2024
Thomas Schinecker, chief executive officer of Roche
FinanceSwiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
By Prarthana PrakashJuly 29, 2024
1...
  • 10
  • 11
  • 12
  • 13
  • 14
...100
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Investing
Mark Cuban admits he made a mistake letting go of the Mavericks: 'I don't regret selling. I regret who I sold to'placeholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.